iBio, Inc. (IBIO)

iBio, Inc. Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	7	18	10	58	329	263
Market Cap Growth	716.05%	77.58%	-82.21%	-82.49%	25.19%	1783.71%
Enterprise Value	5	31	22	37	258	286
Last Close Price	0.76	2.11	12.20	132.00	755.00	1110.00
PS Ratio	15.17	80.87	-	30.57	138.74	160.42
PB Ratio	0.50	0.85	0.67	0.91	3.03	4.64
P/TBV Ratio	0.96	1.14	1.02	0.98	3.06	4.74
EV/Sales Ratio	13.92	137.12	-	19.52	108.69	174.78
Debt / Equity Ratio	0.34	0.23	1.14	0.41	0.30	0.58
Asset Turnover	0.01	0.01	-	0.02	0.02	0.03
Inventory Turnover	-	-	-	-	3.54	-
Quick Ratio	1.49	3.70	0.20	1.13	14.66	11.60
Current Ratio	1.76	4.08	1.19	1.48	15.74	11.79
Return on Equity (ROE)	-123.28%	-84.15%	-74.33%	-34.31%	-28.11%	-55.68%
Return on Assets (ROA)	-34.91%	-29.73%	-25.58%	-15.07%	-16.05%	-14.03%
Return on Capital (ROIC)	-43.11%	-35.24%	-29.46%	-16.10%	-16.77%	-14.98%
Earnings Yield	-258.03%	-136.88%	-634.44%	-87.34%	-7.05%	-6.26%
FCF Yield	-217.92%	-103.12%	-359.78%	-77.80%	-10.63%	-5.49%
Buyback Yield / Dilution	-557.77%	-525.98%	-40.35%	-11.45%	-211.53%	-231.79%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q